跳至主要内容
临床试验/IRCT20190616043906N1
IRCT20190616043906N1招募中3 期

Comparison of efficacy of Colistin IV, Colistin Nebulized with Colistin IV, Meropenem in the treatment of ventilator associated pneumonia caused by MDR gram negative microorganisms, a randomized clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 no limit(—)
性别
All

入选标准

  • Diagnosis of pneumonia 48 hours after intubation (radiographical, laboratory and clinical findings along with a positive tracheal aspirate culture)

排除标准

  • Signs of previous pneumonia at the time of intubation
  • No concomitant antibiotics indicated to treat pneumonia other than the study (but allowed for other infections)
  • Patients with a positive culture but no clinical and radiological findings for pneumonia
  • An antibiogram sensitive to any antibiotocs else than polymixins
  • Any history of allergy and seizure caused by Carbapenems/Colistin

研究者

相似试验

ebulized colistin in pneumonia | 临床试验